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Abstract
Background: Burkholderia pseudomallei is a soil-dwelling saprophyte and the cause of melioidosis.
Horizontal gene transfer contributes to the genetic diversity of this pathogen and may be an
important determinant of virulence potential. The genome contains genomic island (GI) regions
that encode a broad array of functions. Although there is some evidence for the variable
distribution of genomic islands in B. pseudomallei isolates, little is known about the extent of
variation between related strains or their association with disease or environmental survival.
Results: Five islands from B. pseudomallei strain K96243 were chosen as representatives of
different types of genomic islands present in this strain, and their presence investigated in other B.
pseudomallei. In silico analysis of 10 B. pseudomallei genome sequences provided evidence for the
variable presence of these regions, together with micro-evolutionary changes that generate GI
diversity. The diversity of GIs in 186 isolates from NE Thailand (83 environmental and 103 clinical
isolates) was investigated using multiplex PCR screening. The proportion of all isolates positive by
PCR ranged from 12% for a prophage-like island (GI 9), to 76% for a metabolic island (GI 16). The
presence of each of the five GIs did not differ between environmental and disease-associated
isolates (p > 0.05 for all five islands). The cumulative number of GIs per isolate for the 186 isolates
ranged from 0 to 5 (median 2, IQR 1 to 3). The distribution of cumulative GI number did not differ
between environmental and disease-associated isolates (p = 0.27). The presence of GIs was defined
for the three largest clones in this collection (each defined as a single sequence type, ST, by
multilocus sequence typing); these were ST 70 (n = 15 isolates), ST 54 (n = 11), and ST 167 (n =
9). The rapid loss and/or acquisition of gene islands was observed within individual clones.
Comparisons were drawn between isolates obtained from the environment and from patients with
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BMC Genomics 2008, 9:190 http://www.biomedcentral.com/1471-2164/9/190melioidosis in order to examine the role of genomic islands in virulence and clinical associations.
There was no reproducible association between the individual or cumulative presence of five GIs
and a range of clinical features in 103 patients with melioidosis.
Conclusion: Horizontal gene transfer of mobile genetic elements can rapidly alter the gene
repertoire of B. pseudomallei. This study confirms the utility of a range of approaches in defining the
presence and significance of genomic variation in natural populations of B. pseudomallei.
Background
Burkholderia pseudomallei is a soil dwelling Gram-negative
bacterium and the cause of melioidosis, a serious human
infection commonly reported in northeast Thailand and
northern Australia [1,2]. The genome of this biothreat
agent contains genomic island (GI) regions that have
properties indicative of horizontal gene transfer, i.e. DNA
displaying anomalies in % G+C content or dinucleotide
frequency signature, and/or the presence of coding
sequences (CDSs) with similarities to genes associated
with mobile genetic elements such as insertion sequence
(IS) elements, bacteriophages and plasmids. Sixteen GIs
were identified in the genome of B. pseudomallei strain
K96243 [3], comprising approximately 6% of the
genome. Screening of 40 clinical and environmental iso-
lates of B. pseudomallei for the presence of selected K96243
GIs found that there was variable distribution [3], suggest-
ing that horizontal gene transfer contributes to genome
diversity. Genomic islands in other bacterial species
encode many different functions, and selection may
favour the maintenance of islands that increase fitness in
a specialized environmental niche. Genomic islands also
play a pivotal role in virulence of a large number of bacte-
rial pathogens, carrying clusters of virulence genes encod-
ing a wide range of functions including iron uptake
systems, adhesins, superantigens, and genes that alter the
antibiotic resistance phenotype [4].
B. pseudomallei is found in the soil and surface water of
endemic areas and usually enters the host via cuts and
abrasions in the skin or by inhalation following contact
with contaminated water or soil. Once inside the body,
the time taken for disease symptoms to appear can vary
from hours to years. In some cases, B. pseudomallei infec-
tion does not cause overt disease around the time of expo-
sure, but rather results in a state of bacterial dormancy in
the host for many years before causing disease in later life.
The most remarkable example is that of a second world
war veteran who developed melioidosis 62 years after
returning to the US from SE Asia [5].
The clinical symptoms of melioidosis are so varied that
the disease has been termed "the great mimicker" [6]. Dis-
ease manifestations are extremely wide ranging and vary
from acute, fulminant sepsis to localized disease. The
most frequent picture is a septicemic illness, often associ-
ated with bacterial dissemination to distant sites such as
the liver and spleen [2]. Pneumonia occurs in around
50% of patients. Other sites of infection include bone,
joints, skin, soft tissue, prostate and the central nervous
system. Overall mortality is around 50% in northeast
Thailand (35% in children) [2], and 19% in Australia [1].
The basis for marked variability in clinical presentation
and disease severity is unknown. Host determinants such
as diabetes mellitus and renal failure represent risk factors
for infection with B. pseudomallei [1,7], but no host factors
have been associated with specific clinical features. The
role of bacterial factors in determining disease variability
and severity is poorly understood.
In this study we examined the distribution of a represent-
ative sample of five GIs previously described for B. pseu-
domallei K96243. In silico analysis of 10 genome sequences
revealed the micro-evolutionary processes responsible for
the short-term diversification of these regions. Multiplex
PCR screening was used to investigate GI presence in B.
pseudomallei isolates from NE Thailand. Rapid loss and/or
acquisition of gene islands was observed by assaying the
presence of islands within isolates belonging to single
clones (as defined by multilocus sequence typing (MLST))
[8]. Comparisons were drawn between isolates obtained
from the environment and from patients with melioidosis
in order to examine the role of genomic islands in viru-
lence.
Results and Discussion
Overview of five genomic islands in B. pseudomallei strain 
K96243
The five genomic islands studied here include examples of
a prophage (GI 2; φK96243) which has been shown to be
mobile in this strain, two prophage-like islands (GI 6 and
GI 9), a putative integrated plasmid (GI 11), and a puta-
tive metabolic island (GI 16) that lacks any obvious genes
for mobilisation or integration [3]. The five islands are a
representative sample of the islands present in a single
strain, and provide a snapshot of GI diversity. The mosaic
structure and variable composition of GIs means that it is
impractical to attempt to capture the full gamut of ele-
ments circulating in a large natural bacterial population,
and we therefore focused our analysis on a representative
sample of GIs identified in K96243.Page 2 of 10
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B. pseudomallei K96243 is provided in Additional file 1,
and a comprehensive list of the CDSs contained in these
regions is provided in Additional File 2. The overwhelm-
ing majority of CDSs that are not phage or plasmid related
are of unknown function. GIs 2, 6, 9 and 11 contain CDSs
with no homology to known metabolic or putative viru-
lence proteins. GIs 2, 6 and 11 contain low % GC regions
relative to the rest of the island, indicating that the islands
are mosaic and some genes may have been acquired
recently; new gene acquisitions may have atypical
sequence characteristics that are maintained over a rela-
tively short time frame. GI 16 contains several CDSs with
similarity to known virulence determinants, including a
putative haemagglutinin and processing protein, and
genes involved in the acquisition and utilization of nutri-
ents. The abundance of CDSs on this island that encode
functions that potentially broaden the metabolic reper-
toire of K96243 (for example possible sugar utilization
and amino acid catabolism gene clusters and accompany-
ing regulators), has led to this island being previously des-
ignated a putative metabolic island [3]. CDSs in this
island region exhibited varying levels of similarity to pro-
teins from a range of taxonomically diverse organisms,
and it was not possible to speculate on the likely source of
this island region from similarity searches.
Comparative genomic analysis of genomic islands
In silico analysis of the five GIs was undertaken to explore
the degree of variability in presence, structure and chro-
mosomal insertion site. Nine isolates that have been
sequenced or are currently undergoing whole genome
sequencing by JCVI (J. Craig Venter Institute) were exam-
ined and compared with strain K96243, which has been
sequenced by the Wellcome Trust Sanger Institute [3]
(Table 1). Seven JCVI isolates and K96243 are unique
strains, but strains 1106b and 1710b were recovered from
patients presenting with recurrent melioidosis due to
relapse (failure to eradicate the primary infection), and
are identical by PFGE and MLST to strains 1106a and
1710a, respectively.
We examined the structure, composition and insertion
site of the five GIs using the ten available genome
sequences (complete and assemblies from unfinished
genomes). GIs 2, 6, 9 and 11 all had flanking repeats, inte-
grases, and mobile element-like genes, consistent with the
suggestion that these were recently acquired mobile
genetic elements. There were two instances where the GI
was absent at the predicted site of insertion, but DNA with
extended similarity to the island was detected elsewhere
in the genome (one example each for GI 2 and GI 9). In
B. pseudomallei strain 1655 a prophage with extended sim-
ilarity to GI 2 (95–99% DNA identity over ~95% of the
length of GI 2; data not shown), is integrated at an alter-
native tRNA gene on chromosome 1 (tRNA-Arg as
opposed to tRNA-Phe). In the genome of K96243, GI 12
is found at this alternative locus. In 1106a an island with
similarity to GI 2 is inserted at an alternative locus (tRNA-
Ser) on chromosome 1. An identical island is present in
1106b. The 1106a island has a mosaic structure; approxi-
mately half of the island is highly similar (95–99% DNA
identity) to the K96243 GI 9, with the other half exhibit-
ing no similarity (see Additional file 3). The location of
these sequences at alternative loci may be due to genomic
rearrangement following divergence from a common
ancestor carrying the island, or may reflect the presence of
multiple insertion sites for related mobile genetic ele-
ments in the B. pseudomallei genome.
Comparative analysis of GI 11 region identified an alter-
native island inserted at orthologous sites in the 1106a
and 1106b genomes (Table 1; Figure 1). This novel island
is larger than the K96243 GI 11 (~35 kb). Comparison of
the islands in 1106a and 1106b demonstrated that they
are virtually identical except for a small internal indel
Table 1: Distribution of islands in sequenced B. pseudomallei strains
BP strain Origin GI 2 GI 6 GI 9 GI 11 GI 16
K96243 Thailand + + + + +
406e Thailand - - - - +/- (BPSS2060 to BPSS2076)
1106a† Thailand - - -* Alt +/- (BPSS2057 to BPSS2076)
1106b† Thailand - - -* Alt +/- (BPSS2057 to BPSS2076)
1710a† Thailand - - - - +/- (BPSS2057 to BPSS2076)
1710b† Thailand - - - - +/- (BPSS2057 to BPSS2076)
Pasteur 6068 Vietnam + - - - +/- (BPSS2057 to BPSS2076)
S13 Singapore + - - - +/- (BPSS2057 to BPSS2076)
668 Australia - - - - -
1655 Australia - * - - - + *
† Strain pairs 1106a & 1106b, and 1710a and 1710b were obtained from two patients who each relapsed (from a persistent focus) 3 years after the 
primary episode of melioidosis. 'a' denotes primary isolate and 'b' denotes relapse isolate.
- Island absent; + Island present; +/- Island partially present (CDSs missing); -* Island absent at the site of insertion but similar region present 
elsewhere in the genome; +* Island present and contains extra sequence; Alt Alternative island present at this site (no sequence similarity)Page 3 of 10
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BMC Genomics 2008, 9:190 http://www.biomedcentral.com/1471-2164/9/190region that is present in 1106a but absent in 1106b. The
indel region is between two identical IS elements in
1106a. In 1106b there is a single insertion sequence (IS)
element, suggesting that recombination between the IS
elements may have led to the deletion in this region in
1106b. Although the 1106a and 1106b islands appear to
be inserted at the same site as the K96243 GI 11, the
attachment sites are different. In the case of K96243, the
attachment site is an Ala tRNA, generating 45 mer perfect
repeats that flank the island. The GI 11 regions in 1106a
and 1106b are next to the Ala tRNA, but the flanking DNA
in both islands is a 13 mer sequence that does not appear
to be part of the Ala tRNA, or surrounding sequence in
K96243. The alternative GI 11 in 1106a and 1106b con-
tains a putative filamentous haemagglutinin and process-
ing protein that are similar to proteins found in B.
thailandensis (BTH_I2723 and BTH_I2721 respectively).
The homologues of the filamentous haemagglutinin and
processing protein in B. thailandensis strain E264 are not
in an orthologous position relative to the B. pseudomallei
Comparison of the GI 11 regions in B. pseudomallei strains K96243, 1106a and 1106bFigure 1
Comparison of the GI 11 regions in B. pseudomallei strains K96243, 1106a and 1106b. The results of a TBLASTX 
comparison of the GI 11 regions from strains K96243 (top) 1106a (middle) and 1106b (bottom) are displayed using the 
Artemis Comparison Tool (ACT) [21]. A plot of the % GC content of each sequence is displayed. The colored bars separating 
each genome (red and blue) represent similarity matches identified by BLASTN analysis [22]. Red lines link matches in the same 
orientation; blue lines link matches in the reverse orientation.
0 50 kbPage 4 of 10
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BMC Genomics 2008, 9:190 http://www.biomedcentral.com/1471-2164/9/190GI 11 flanking DNA. In the genome of this closely related
species, an alternative GI 11 is present (BTH_I3130 to
BTH_I3143), which is integrated at the orthologous
attachment site (Ala tRNA) to the GI 11 in B. pseudomallei
K96243.
Micro-evolutionary diversification was also observed in
GI 16, in which an internal deletion encompassing CDSs
BPSS2057 to BPSS2076 was noted in four unique strains
and both relapse isolates (Table 1). Strain 406e also con-
tains the island, but has a deletion encompassing the
same region (BPSS2060 to BPSS2076) that has different
boundaries, suggesting that the deletion occurred inde-
pendently in this strain. One other strain (1655) con-
tained the complete GI 16 plus additional sequence, both
within the island and downstream of it. Figure 2 shows a
comparison of GI 16 regions in strains K96243, 1655 and
1710b (which has the internal deletion of BPSS2057 to
BPSS2076). The lack of integrases and other mobile
genetic element CDSs, and high variability in CDS con-
Comparison of the GI 16 regions in B. pseudomallei strains 1655, K96243 and 1710bFigure 2
Comparison of the GI 16 regions in B. pseudomallei strains 1655, K96243 and 1710b. The results of a BLASTN com-
parison of the GI 16 regions from strains 1655 (top), K96243 (middle) and 1710b (bottom) are displayed using the Artemis 
Comparison Tool (ACT) [21]. A plot of the % GC content of each sequence is displayed. The colored bars separating each 
genome (red and blue) represent similarity matches identified by BLASTN analysis [22]. Red lines link matches in the same ori-
entation; blue lines link matches in the reverse orientation.
0 100 kbPage 5 of 10
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BMC Genomics 2008, 9:190 http://www.biomedcentral.com/1471-2164/9/190tent, suggests that GI 16 is distinct from the other GIs con-
sidered here which have structures more typical of mobile
genetic elements. GI 16 has a mosaic structure consistent
with a long history of multiple insertion and deletion
events. The role of horizontal gene transfer in the evolu-
tion of this region is supported by the anomalous GC
composition (Figure 2).
Presence of five genomic islands in B. pseudomallei
By assaying the presence of GIs in a large strain collection
within the population framework provided by MLST data,
it is possible to investigate the frequency of island acqui-
sition and loss, as well as their possible role in disease.
Presence or absence of the five GIs was defined for 186
Thai isolates obtained from the environment (n = 83) and
from patients with melioidosis (n = 103). The proportion
of all isolates positive by PCR varied between GIs, and
ranged from 12% for a prophage-like island (GI 9) to 76%
for a metabolic island (GI 16) (Table 2). These propor-
tions are consistent with previous findings reported for 40
Thai isolates [3], with the exception that GI 2 and GI 6
were detected more frequently in the larger bacterial pop-
ulation examined here (72% versus 53% for GI 2, and
23% versus 8% for GI 6, p = 0.02 & p = 0.03, respectively).
Isolates in both collections were from northeast Thailand.
A small proportion of strains were positive for one or two
gene targets for a given GI, and gave an amplification
product for PCR across the putative insertion site (data
not shown). One explanation for this is that GIs may have
alternative insertion sites. This explanation was shown to
be true for some islands on the comparative genomic
analysis of the sequenced strains, described above.
Variability in genomic islands between clones of B. 
pseudomallei
We explored the mobility of the five GIs by examining
whether the presence of islands reflects the underlying
population structure, such that closely related isolates
might have more similar GI repertoires than distantly
related isolates. This was possible as all of the isolates used
in this study had been characterized previously by MLST
[9]. Analysis was restricted to the three largest clones (ST
70 (n = 15 isolates, allelic profile (gene order ace-gltB-
gmhD-lepA-lipA-narK-ndh) 3-4-11-3-5-4-6), ST 54 (n = 11,
allelic profile 3-1-3-3-1-2-1), and ST 167 (n = 9, allelic
profile 1-1-4-1-1-3-1)). Variation in the GI repertoire was
defined within and between these clones. There was con-
siderable variability in presence of the five GIs between
the three clones (Table 3). For example, GI 6 was more
common in isolates belonging to ST 70 than the other two
clones (p = 0.04), GI 16 was ubiquitous in ST 54 isolates
but present in three quarters or less of the other two STs (p
= 0.04), and GI 11 was only detected in 4 isolates belong-
ing to ST 70. An analysis of the difference in GIs between
environmental and clinical isolates in each clone was not
performed because of the lack of statistical power.
These findings suggest that horizontal gene transfer can
alter the gene repertoire ("accessory genome") of this spe-
cies very rapidly, i.e. before any observable changes in the
vertically inherited "core" genome, and is consistent with
the hypothesis that isolates that are identical by MLST
might exploit different ecological niches [10]. The MLST
data for B. pseudomallei has revealed a very high frequency
of homologous recombination resulting in limited clus-
tering and low levels of linkage disequilibrium [8,11,12].
Our results also suggest that the loss and acquisition of
Table 2: Detection by PCR of five genomic islands in 186 B. pseudomallei isolates from northeast Thailand
Genomic island Positive (%) Positive (%)
All isolates (n = 186) Soil (n = 83) Invasive (n = 103) Pa
2 133 (72%) 62 (75%) 71 (69%) 0.39
6 43 (23.%) 22 (27%) 21 (20%) 0.33
9 22 (12%) 11 (13%) 11 (11%) 0.59
11 39 (21%) 15 (18%) 24 (23%) 0.38
16 142 (76%) 66 (80%) 76 (74%) 0.36
Cumulative number of genomic islands All isolates Soil Invasive Pb
0 5 (3%) 1 (1%) 4 (4%) 0.28
1 46 (25%) 20 (24%) 26 (25%)
2 84 (45%) 36 (43%) 48 (47%)
3 40 (22%) 20 (24%) 20 (19%)
4 10 (5%) 6 (7%) 4 (4%)
5 1 (0.5%) 0 1 (1.0%)
a Chi-square test; b Student's t testPage 6 of 10
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contributes to the dynamism of the genome. However, it
should be noted that these two processes are distinct, and
that a high rate of island transfer does not necessarily pre-
dict a high rate of homologous recombination or vice
versa. For example, MLST data for the Gram-positive path-
ogen Staphylococcus aureus has revealed only modest rates
of homologous recombination, yet the "accessory"
genome of this species is known to change very rapidly
[10,13-16]. B. pseudomallei represents an alternative sce-
nario, the data indicating both high rates of homologous
recombination together with rapid changes in GI reper-
toire.
Comparison of the presence of genomic islands in soil and 
invasive isolates
We examined the hypothesis that the GIs play a role in the
ability to cause human disease by testing whether the
presence of GIs was significantly different in clinical and
environmental isolates. We found that there was no sig-
nificant difference in the presence of any of the GIs
between these two groups (p > 0.05 for all five islands)
(Table 2). We considered the possibility that combina-
tions of GIs could alter the ability to cause disease through
either a cumulative or synergistic effect. We defined the
cumulative number of GIs per isolate for the 186 Thai iso-
lates; this ranged from 0 to 5 (median 2, IQR 1 to 3)
(Table 2). The distribution of cumulative GI number did
not differ between environmental and disease-associated
isolates (p = 0.27) (Table 2). These data indicate that none
of the islands examined were numerically associated
either individually or on a cumulative basis with the abil-
ity to cause melioidosis.
Relationship between clinical features and genomic islands 
in disease-associated isolates
The lack of association between the presence of the five
GIs and the ability to cause human disease does not
exclude the possibility that these GIs are associated with
specific clinical features or outcome. To study this, we
undertook a detailed statistical analysis of the relationship
between a range of clinical features in 103 patients with
melioidosis and the presence of GIs in their associated B.
pseudomallei isolates. Univariate analysis was used to com-
pare the presence of each GI and their cumulative number
with the presence of blood cultures positive for B. pseu-
domallei, presence of ultrasound confirmed abscess(es) in
liver and/or spleen, pneumonia, multiple organ involve-
ment, the presence on admission or subsequent develop-
ment of hypotension, impaired renal function, impaired
liver function and death during hospital admission. GI 6
was negatively associated with positive blood culture (OR
0.30; 95%CI 0.11–0.82, p = 0.02), and GI 11 was nega-
tively associated with impaired renal function (OR 0.36;
95%CI 0.14–0.94, p = 0.04). Cumulative number of GIs
was negatively associated with impaired renal function
(OR 0.54; 95%CI 0.33–0.86, p = 0.01). These significant
associations could be a chance finding related to multiple
comparisons. To test this hypothesis, the presence of GIs
were determined for an independent set of 255 invasive
isolates obtained from patients with melioidosis present-
ing to Sappasithiprasong Hospital between 2002–2003.
There was no significant association between GI 6 and
positive blood cultures (OR 1.12; 95%CI 0.51–2.43, p=
0.78), or GI 11 and impaired renal function (OR 0.67;
95%CI 0.34–1.32, p = 0.25). Cumulative number of GIs
was not negatively associated with impaired renal func-
tion. We conclude that there were no significant associa-
tions between clinical features and any of the five GIs
examined.
Conclusion
This survey of divergent putative GIs in a well-defined and
clinically significant B. pseudomallei population has dem-
onstrated that genetic exchange is widespread. Our in silico
analysis provided evidence that GI 16 may represent a
composite region rather than a genomic island, and
defined a novel GI at the predicted insertion site for GI 11.
A detailed analysis of the relationship between five GIs
and both the ability to cause disease and a range of clinical
features failed to show an association between the two.
However, a previous study that utilized MLST to examine
Table 3: Presence of genomic islands in the three largest clones as defined by multilocus sequence type
Genomic island All isolates Sequence type
ST 70 ST 54 ST 167 Pa
Number of isolates 186 15 11 9 -
GI 2 133 (72%) 11 (73%) 6 (55%) 6 (67%) 0.60
GI 6 43 (23%) 8 (53%) 1 (9%) 1 (11%) 0.04
GI 9 22 (12%) 0 1 (9%) 0 0.57
GI 11 39 (21%) 4 (27%) 0 0 0.08
GI 16 143 (77%) 10 (67%) 11 (100%) 5 (56%) 0.04
a Fisher's exact testPage 7 of 10
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BMC Genomics 2008, 9:190 http://www.biomedcentral.com/1471-2164/9/190the bacterial genotype of 266 B. pseudomallei isolates (83
soil and 183 invasive) obtained from northeast Thailand
reported that isolates from patients with melioidosis were
significantly over-represented in the 10 largest clones [9].
A classification index applied to examine differences in
the frequency of STs, and the frequency of alleles at spe-
cific loci, also demonstrated a significant difference
between the two bacterial populations. This indicates that
bacterial genotypes were not distributed randomly
between soil and invasive isolate groups, an observation
that could be accounted for by variations in the accessory
genome of some strains that leads to heightened viru-
lence. Further evidence for this suggestion comes from a
study in Australia, in which variability in genome content
between two Australian B. pseudomallei isolates was uti-
lized to define sequence variability and to develop a vari-
able amplicon typing scheme designed to score the
presence of 14 PCR amplicons in Thai and Australian iso-
lates [17]. Isolates clustered into groups, one of which was
mostly associated with severe disease.
Our study confirms the utility of a range of approaches in
defining the presence and significance of genomic varia-
tion in natural populations of B. pseudomallei. Further
studies are required to determine the full extent of varia-
bility in GIs, and their relationship to biological fitness in
the environment and to disease pathogenesis in the
human host.
Methods
Bacterial isolates
A total of 186 B. pseudomallei isolates were obtained from
northeast Thailand. Of these, 83 were isolated from the
environment in the province of Ubon Ratchathani, north-
east Thailand between 1990 and 2003. All sites were
flooded rice paddies, the majority of which were sampled
after ploughing but before planting. Environmental sam-
ples were processed for the presence of B. pseudomallei, as
previously described [18]. A further 103 isolates were cul-
tured from consecutive patients presenting with melioido-
sis during 2001 to Sappasithiprasong hospital, Ubon
Ratchathani. Clinical manifestations of infection were
varied; 63 patients had positive blood cultures with or
without involvement of one or more organs or tissues,
and 40 patients had negative blood cultures but one or
more organs or tissues involved. All isolates were main-
tained at -70°C in TSB with 15% glycerol.
Detection of genomic islands
A single bacterial colony was inoculated into TSB and
incubated overnight in air at 37°C, after which genomic
DNA was extracted using the Wizard Genomic DNA puri-
fication kit (Promega, WI, USA). The presence or absence
of five GIs (GI 2, prophage φK96243; GI 6, prophage-like;
GI 9, prophage-like; GI 11, putative integrated plasmid;
and GI 16, metabolic island) [3], was defined by PCR.
Two target genes were selected for each island, as follows:
BPSL0130 and BPSL0135 (GI 2), BPSL 1138 and
BPSL1155 (GI 6), BPSL2578 and BPSL2579 (GI 9),
BPSL3258 and BPSL3260 (GI 11), and BPSS2053 and
BPSS2061 (GI 16). Targets encoded predominantly puta-
tive hypothetical proteins with unknown functions.
Genes that encoded functions necessary for the transfer
and maintenance of the island such as integrases were
avoided as similar sequences may be found on other unre-
lated islands. Primers and cycling conditions are as
described by Holden et al. [3] with the exception of the
following: BPSL1030-f (5'-GCGCCGCTCGACTTCCT-
TCTCT), BPSL1030-r (5'-GAGGGGCCGGACTGCTACT-
TCAC); BPSL1138-f (5'-GATTTGGTTGGCGTCCGTGTT
T), BPSL1138-r (5'-CGACCTTGGCCGAATTATGTGA);
BPSS2061-f (5'-AACGCTCGCGCCCTTTAC), BPSS2061-r
(5'-AATGCCCTTCCGAATCCTTTATG). A positive control
(B. pseudomallei K96243) and a negative control (reaction
mixture without DNA) were included in each PCR run. To
verify the absence of the genomic islands, a second round
of PCR was performed for all isolates to amplify the puta-
tive insertion site by using primers situated within genes
immediately abutting each putative island, as previously
described [3]. The expected result was either no PCR prod-
uct (interpreted as being consistent with the presence of
the island) or a product whose size was consistent with
amplification across the insertion site minus island PCR.
Amplifications were performed using a PTC-0200 DNA
engine (MJ Research, Cambridge, MA) with Taq polymer-
ase (Promega), and aliquots of reaction mixtures were
analyzed by 1% agarose gel electrophoresis. An island was
classified as present if either or both target genes were pos-
itive, and negative if no amplification products were
obtained for either target gene but a product was ampli-
fied across the putative insertion site.
Clinical definitions
Multiple organ involvement was defined when there was
>1 non-contiguous focus of infection, not including
blood. Pneumonia was defined as the presence of clinical
features plus radiographic changes and/or sputum culture
positive for B. pseudomallei. Impaired renal function was
defined as an estimated glomerular filtration rate below
60 mL/min/1.73 m2 during admission. Glomerular filtra-
tion rate was estimated using an abbreviated form of the
Modification of Diet in Renal Disease study equation
[19]. Impaired hepatic function was defined as an eleva-
tion of aminotransferase more than 5 times the upper
normal limit, or the presence of jaundice during admis-
sion. Hypotension was defined as a systolic BP <90
mmHg on or during admission.Page 8 of 10
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MLST has been performed by us for all of the Thai isolates
used in this study [9], MLST profiles for which are main-
tained on the B. pseudomallei MLST web site [20].
Genomic islands were previously identified in the
genome of B. pseudomallei K96243 (accession numbers
BX571965 and BX571966) [3]. Comparison of genome
sequences was performed with ACT (Artemis Comparison
Tool) [21] using BLASTN and TBLASTX [22]. Compari-
sons were made using the 3 other complete B. pseudomallei
genome sequences 1106a (accession numbers CP000572
and CP000573), 1710b (accession numbers CP000124
and CP000125) and 668 (accession numbers CP000570
and CP000571), the 6 B. pseudomallei strains currently
undergoing whole genome sequencing (406e, 1106b,
1710a, Pasteur 6068, S13, and 1655) by JCVI [23], and B.
thailandensis E264 (accession numbers CP000086 and
CP000085) [24].
Statistical tests were performed using the statistical pro-
gram STATA/SE, version 9.0 (StataCorp LP, College Sta-
tion, Tx.). Proportions were compared using the Chi-
square test, or Fisher's exact test where appropriate. Com-
parison of continuous data was performed using the Stu-
dent's t test. Unifactorial analysis was used to examine the
association between presence of each GI, cumulative
number of GIs and clinical factors.
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